330 related articles for article (PubMed ID: 10079189)
21. Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis.
Cong SY; Pepers BA; Roos RA; van Ommen GJ; Dorsman JC
Exp Neurol; 2006 Jun; 199(2):257-64. PubMed ID: 16380118
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of neurite outgrowth and promotion of cell death by cytoplasmic soluble mutant huntingtin stably transfected in mouse neuroblastoma cells.
Ye C; Zhang Y; Wang W; Wang J; Li H
Neurosci Lett; 2008 Sep; 442(1):63-8. PubMed ID: 18650014
[TBL] [Abstract][Full Text] [Related]
23. Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.
Ho LW; Brown R; Maxwell M; Wyttenbach A; Rubinsztein DC
J Med Genet; 2001 Jul; 38(7):450-2. PubMed ID: 11432963
[TBL] [Abstract][Full Text] [Related]
24. Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease.
Lecerf JM; Shirley TL; Zhu Q; Kazantsev A; Amersdorfer P; Housman DE; Messer A; Huston JS
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4764-9. PubMed ID: 11296304
[TBL] [Abstract][Full Text] [Related]
25. Polyglutamine pathogenesis.
Ross CA; Wood JD; Schilling G; Peters MF; Nucifora FC; Cooper JK; Sharp AH; Margolis RL; Borchelt DR
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1005-11. PubMed ID: 10434299
[TBL] [Abstract][Full Text] [Related]
26. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
Wang H; Lim PJ; Karbowski M; Monteiro MJ
Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
[TBL] [Abstract][Full Text] [Related]
27. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.
Cyr M; Sotnikova TD; Gainetdinov RR; Caron MG
FASEB J; 2006 Dec; 20(14):2541-3. PubMed ID: 17065224
[TBL] [Abstract][Full Text] [Related]
28. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.
Martindale D; Hackam A; Wieczorek A; Ellerby L; Wellington C; McCutcheon K; Singaraja R; Kazemi-Esfarjani P; Devon R; Kim SU; Bredesen DE; Tufaro F; Hayden MR
Nat Genet; 1998 Feb; 18(2):150-4. PubMed ID: 9462744
[TBL] [Abstract][Full Text] [Related]
29. Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis.
Sugars KL; Brown R; Cook LJ; Swartz J; Rubinsztein DC
J Biol Chem; 2004 Feb; 279(6):4988-99. PubMed ID: 14627700
[TBL] [Abstract][Full Text] [Related]
30. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.
Scherzinger E; Sittler A; Schweiger K; Heiser V; Lurz R; Hasenbank R; Bates GP; Lehrach H; Wanker EE
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4604-9. PubMed ID: 10200309
[TBL] [Abstract][Full Text] [Related]
31. HAP1 can sequester a subset of TBP in cytoplasmic inclusions via specific interaction with the conserved TBP(CORE).
Prigge JR; Schmidt EE
BMC Mol Biol; 2007 Sep; 8():76. PubMed ID: 17868456
[TBL] [Abstract][Full Text] [Related]
32. Interaction of Huntington disease protein with transcriptional activator Sp1.
Li SH; Cheng AL; Zhou H; Lam S; Rao M; Li H; Li XJ
Mol Cell Biol; 2002 Mar; 22(5):1277-87. PubMed ID: 11839795
[TBL] [Abstract][Full Text] [Related]
33. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
Banerjee M; Datta M; Bhattacharyya NP
Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
[TBL] [Abstract][Full Text] [Related]
34. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
[TBL] [Abstract][Full Text] [Related]
35. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription.
Kegel KB; Meloni AR; Yi Y; Kim YJ; Doyle E; Cuiffo BG; Sapp E; Wang Y; Qin ZH; Chen JD; Nevins JR; Aronin N; DiFiglia M
J Biol Chem; 2002 Mar; 277(9):7466-76. PubMed ID: 11739372
[TBL] [Abstract][Full Text] [Related]
36. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.
Bao J; Sharp AH; Wagster MV; Becher M; Schilling G; Ross CA; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):5037-42. PubMed ID: 8643525
[TBL] [Abstract][Full Text] [Related]
37. Aggregation of truncated GST-HD exon 1 fusion proteins containing normal range and expanded glutamine repeats.
Hollenbach B; Scherzinger E; Schweiger K; Lurz R; Lehrach H; Wanker EE
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):991-4. PubMed ID: 10434297
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
Lee WC; Yoshihara M; Littleton JT
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
[TBL] [Abstract][Full Text] [Related]
39. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.
Holbert S; Denghien I; Kiechle T; Rosenblatt A; Wellington C; Hayden MR; Margolis RL; Ross CA; Dausset J; Ferrante RJ; Néri C
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1811-6. PubMed ID: 11172033
[TBL] [Abstract][Full Text] [Related]
40. Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins.
Mitsui K; Nakayama H; Akagi T; Nekooki M; Ohtawa K; Takio K; Hashikawa T; Nukina N
J Neurosci; 2002 Nov; 22(21):9267-77. PubMed ID: 12417652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
